Four out of five men and women in the United States will be overweight or obese by 2050 if current trends hold, a new ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

NEW YORK >> President-elect Donald Trump announced today he has selected Robert F. Kennedy Jr., an environmental activist who has spread misinformation on vaccines, to lead the Department of Health ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

President-elect Donald Trump said on Thursday he has selected Robert F. Kennedy Jr., an environmental activist who has spread ...

Nearly three quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

The study notes that overweight and obesity have been a growing problem for the United States for years. Obesity rates for adults and older adolescents doubled over the past three decades, and the ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...